
East India Pharmaceutical Works Limited Unlisted Share Price
As of , the indicative unlisted share price of East India Pharmaceutical Works Limited is ₹79 per share. This is an over-the-counter reference price, not a stock-exchange quote.
As of , East India Pharmaceutical Works Limited is not listed on any Indian stock exchange (NSE or BSE) — its shares trade in the unlisted, over-the-counter (pre-IPO) market.
| Price / unit | ₹79 |
|---|---|
| Market cap | ₹53 Cr |
| Min. investment | ₹10,270 |
| Lot size | 130 |
| P/E ratio | 26.33 |
| P/B ratio | 0.78 |
What is East India Pharmaceutical Works Limited?
East India Pharmaceutical Works Limited is an unlisted Pharmaceuticals company whose shares trade in India's over-the-counter (pre-IPO) market and settle in demat form (NSDL/CDSL).
East India Pharmaceutical Works Limited is one of India's oldest pharmaceutical companies, incorporated in 1936 and headquartered in Kolkata, West Bengal. Over more than eight decades, the company has built a presence in the domestic healthcare market through the manufacturing and marketing of a broad range of formulations spanning analgesics, haematinics, digestive enzymes, eye-care products, anti-infectives, and select Ayurvedic and personal-care lines. Its operations combine in-house production with contract manufacturing under a loan-licensing arrangement, supported by facilities in Sarsuna (Kolkata) and Durgapur. The company is often discussed among unlisted names because of its long operating history, established product brands, and a nationwide field and distribution network. As an unlisted security, its shares are not traded on a stock exchange, so they typically carry higher risk and materially lower liquidity than listed equities, and any quoted price is indicative rather than exchange-determined. This information is provided for general awareness only and is not investment advice.
Explore more unlisted shares
Other companies in our curated selection.
Frequently asked questions
No. As of 16 July 2026, East India Pharmaceutical Works Limited is an unlisted company whose shares trade over-the-counter; it would list only if and when it completes an IPO.
The minimum lot is 130 share(s); at the indicative price of about ₹79, that is approximately ₹10,270. Indicative reference, not a quote.
As of 16 July 2026, the indicative unlisted share price of East India Pharmaceutical Works Limited is ₹79 per share. This is an over-the-counter reference price, not a stock-exchange quote.
The ISIN of East India Pharmaceutical Works Limited is INE254X01017. An ISIN is the unique 12-character code that identifies a company's shares in the depository system; this one is verified against NSDL (the National Numbering Agency). You need it to hold or transfer these unlisted shares in your NSDL or CDSL demat account.
East India Pharmaceutical Works Limited is a Kolkata-headquartered pharmaceutical company, incorporated in 1936. It manufactures and markets a range of healthcare products across segments such as analgesics, haematinics, digestive enzymes, eye care, and anti-infectives, alongside select Ayurvedic and personal-care lines, using both in-house and contract manufacturing.
No. East India Pharmaceutical Works Limited is currently an unlisted company and its shares are not traded on the NSE or BSE. Its shares are dealt with in the unlisted market, where any quoted price is indicative rather than determined by a stock exchange.
Unlisted shares are transferred privately rather than through an exchange. For information on availability, the transfer process, and current indicative pricing, you can contact the Unlisted Axis team, who can explain how such transactions are typically handled. This is general information, not investment advice.
Unlisted and pre-IPO shares carry higher risk and lower liquidity than listed equities. They may be difficult to sell quickly, any quoted price is indicative and can move sharply, public disclosures may be limited, and there is no certainty that the company will list. Individuals should conduct their own due diligence and consider their personal circumstances.
They can. If the company declares a dividend, unlisted shareholders are eligible like any other shareholder. Many unlisted firms reinvest profits, so dividends are not guaranteed.
After listing, unlisted shares convert into regular listed shares in your demat account and can be traded on the exchange, usually once any applicable SEBI lock-in period ends.
Unlisted shares are less liquid than listed shares. You can sell when a buyer is available through an off-market transfer; there is no continuous exchange market, so exits can take longer.
Unlisted shares carry higher risk and lower liquidity than listed shares, with fewer disclosures and no live market price. This is general information, not investment advice — assess suitability before investing.
An unlisted share price is an indicative, over-the-counter reference set by demand and supply in private deals between buyers and sellers. There is no live exchange quote, so prices can vary across dealers and over time.
Yes. Unlisted shares are delivered in dematerialised form, so you need an active demat account (NSDL or CDSL). No special account type is required — a regular demat account works.
Unlisted shares are sold through an off-market transfer to a buyer via a registered intermediary, settling from your demat account with a contract note. Liquidity depends on buyer availability, so exits can take longer than listed shares.
East India Pharmaceutical Works Limited vs similar unlisted Pharmaceuticals shares
Indicative over-the-counter prices, as of 16 July 2026. Information only — not a recommendation or ranking.